Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Evotec AG to Acquire Aptuit

Evotec AG
Posted on: 30 Jul 17

Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that it has entered into a definitive agreement with Aptuit Holdings LLC ("Aptuit") under which Evotec will acquire all operational business of Aptuit for $ 300 m (approx. EUR 256 m) to combine the businesses and expand Evotec's role as leading player in integrated outsourced drug discovery and development solutions. In particular, Evotec is aiming for a value chain extension through unique solutions in integrated drug discovery and development. Aptuit is a profitable pharmaceutical services company that offers integrated early discovery to mid-phase drug development services in the biotech and pharmaceutical industry. The Company has approx. 750 employees and three main operating sites in Europe (Verona, Oxford and Basel). The acquisition is expected to close in Q3 2017.

Evotec will pay a total consideration of $ 300 m (approx. EUR 256 m; EUR/$ exchange rate of 1.17) in cash for the acquisition of 100% of the issued and outstanding equity interests of Aptuit Global LLC, Aptuit (Potters Bar) Limited and Aptuit (Switzerland) AG and the funding of all (albeit limited) existing company debt. The acquisition is financed through a mix of existing cash reserves and an additional new EUR 140 m senior debt facility.

Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Phone: +49 (0)40 560 81-0
Fax: +49 (0)40 560 81-222


ISIN: DE0005664809
WKN: 566480
Indices: TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

View source version on

Business Wire

Last updated on: 30/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.